AMINOGLUTETHIMIDE AS 2ND-LINE ENDOCRINE TREATMENT IN METASTATIC BREAST-CANCER

被引：7
|
作者：
PRONZATO, P
ARDIZZONI, A
LIONETTO, R
CONTE, P
ROSSO, R
机构：
来源：
TUMORI | 1985年 / 71卷 / 03期
关键词：
D O I：
10.1177/030089168507100313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：297 / 300
页数：4
相关论文
共 50 条
  • [21] TREATMENT OF POSTMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER WITH AMINOGLUTETHIMIDE
    STIER, G
    GURTLER, R
    SCHMIDT, UM
    MULLER, U
    TANNEBERGER, S
    ZENTRALBLATT FUR GYNAKOLOGIE, 1990, 112 (17): : 1101 - 1104
  • [22] ON THE RELEVANCE OF 2ND-LINE CYTOTOXIC CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER RESISTANT TO STANDARD COMBINATIONS
    PETRU, E
    SCHMAHL, D
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (23) : 790 - 797
  • [23] AMINOGLUTETHIMIDE IN THE MANAGEMENT OF METASTATIC BREAST-CANCER
    SAVARAJ, N
    TRONER, MB
    MEDICAL AND PEDIATRIC ONCOLOGY, 1980, 8 (03): : 251 - 263
  • [24] AMINOGLUTETHIMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER
    NEMOTO, T
    ROSNER, D
    PATEL, JK
    DAO, TL
    CANCER, 1989, 63 (09) : 1673 - 1675
  • [25] 2ND-LINE CHEMOTHERAPY WITH TAUROMUSTINE IN METASTATIC BREAST-CANCER IN POSTMENOPAUSAL WOMEN - A PHASE-II STUDY
    ERNST, P
    BALSLEV, I
    MOURIDSEN, HT
    CANCER TREATMENT REPORTS, 1987, 71 (10): : 987 - 988
  • [26] EXPERIENCE WITH 6-AMINOGLUTETHIMIDE IN THE TREATMENT OF METASTATIC BREAST-CANCER
    KOELMEYER, TD
    STEPHENS, EJW
    WOOD, HF
    CLINICAL ONCOLOGY, 1978, 4 (04): : 323 - 327
  • [27] MEDICAL ADRENALECTOMY WITH AMINOGLUTETHIMIDE (AG) IN TREATMENT OF METASTATIC BREAST-CANCER
    TRONER, MB
    SAVARAJ, N
    FISHMAN, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 291 - 291
  • [28] A PHASE-II STUDY OF CARBOPLATIN AND VINORELBINE AS 2ND-LINE TREATMENT FOR ADVANCED BREAST-CANCER
    IAFFAIOLI, RV
    TORTORIELLO, A
    FACCHINI, G
    SANTANGELO, M
    DESENA, G
    GESUE, G
    BUCCI, L
    SCARAMELLINO, G
    ANASTASIO, E
    FINIZIO, A
    ANTONELLI, B
    VALLEFUOCO, V
    MOSELLA, G
    CAPONIGRO, F
    BRITISH JOURNAL OF CANCER, 1995, 72 (05) : 1256 - 1258
  • [29] DROLOXIFENE IN ADVANCED BREAST-CANCER AS 2ND-LINE OR 3RD-LINE ENDOCRINE THERAPY - A PHASE-II TRIAL
    ENGEL, E
    KLEEBERG, UR
    MARSCHNER, N
    WANDER, HE
    REICHEL, L
    RAUSCHNING, W
    EDLER, L
    ONKOLOGIE, 1992, 15 (05): : 368 - 372
  • [30] 2ND-LINE HORMONOTHERAPY FOR BREAST-CANCER - USELESSNESS OF 1ST-LINE CONTINUATION
    PRONZATO, P
    RUBAGOTTI, A
    AMOROSO, D
    BERTELLI, G
    QUEIROLO, P
    SERTOLI, MR
    ROSSO, M
    GALLOTTI, P
    MONZEGLIO, C
    ROSSO, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 522 - 525
12345